Articles From: Catalyst Paper Q4 results impacted by lower sales volumes, higher maintenance and stronger Canadian dollar to Catamaran to present at the Leerink Swann Global Healthcare Conference


2013/3/5
RICHMOND, BC , March 5, 2013 /PRNewswire/ - Catalyst Paper (TSX:CYT) results in the fourth quarter were negatively impacted by lower sales volumes, higher maintenance spending and a stronger Canadian dollar.
Sign-up for Catalyst Paper Q4 results impacted by lower sales volumes, higher maintenance and stronger Canadian dollar investment picks
2013/2/13
Catalyst Paper to sell its interest in Powell River Energy Canada NewsWire RICHMOND , BC, Feb.
Sign-up for Catalyst Paper to sell its interest in Powell River Energy investment picks
2013/2/13
RICHMOND, BC , Feb.
Sign-up for Catalyst Paper to sell its interest in Powell River Energy investment picks
2013/4/24
Catalyst Paper's offer accepted by holders of US$15.6 million of Floating Rate Senior Secured Notes Canada NewsWire RICHMOND , BC, April 24, 2013 /CNW/ - Catalyst Paper (TSX:CYT) announced today that holders of approximately US$15.6 million of its Floating Rate Senior Secured Notes due 2016 accepted the offer made by Catalyst on March 26, 2013 to purchase up to approximately US$20 million of its Floating Rate Notes.
Sign-up for Catalyst Paper's offer accepted by holders of US$15.6 million of Floating Rate Senior Secured Notes investment picks
2013/4/24
RICHMOND, BC , April 24, 2013 /PRNewswire/ - Catalyst Paper (TSX:CYT) announced today that holders of approximately US$15.6 million of its Floating Rate Senior Secured Notes due 2016 accepted the offer made by Catalyst on March 26, 2013 to purchase up to approximately US$20 million of its Floating Rate Notes.
Sign-up for Catalyst Paper's offer accepted by holders of US$15.6 million of Floating Rate Senior Secured Notes investment picks
2013/3/27
CORAL GABLES, Fla., March 27, 2013 (GLOBE NEWSWIRE) -- Catalyst Pharmaceutical Partners, Inc. (Nasdaq:CPRX) , a specialty pharmaceutical company focused on the development and commercialization of novel prescription drugs targeting rare (orphan) neuromuscular and neurological diseases and disorders, announced today that, on March 25, 2013, the independent Data Monitoring Committee (DMC) overseeing the Company's ongoing pivotal Phase III clinical trial in the United States and Europe evaluating Firdapse™ for the treatment of Lambert-Easton Myasthenic Syndrome (LEMS) recommended that the Company continue the trial as planned based on the committee's review of safety and clinical data from the trial.
Sign-up for Catalyst Pharmaceutical Partners Announces Recommendation of Data Monitoring Committee for Pivotal Phase lll Clinical Trial for Firdapse(TM) investment picks
2013/3/5
CORAL GABLES, Fla., March 5, 2013 (GLOBE NEWSWIRE) -- Catalyst Pharmaceutical Partners, Inc. (Nasdaq:CPRX) , a specialty pharmaceutical company focused on the development and commercialization of novel prescription drugs targeting rare (orphan) neurological diseases and disorders, is pleased to announce today the appointment of Bernardino Mosquera, M.D. as Vice President of Clinical Operations.
Sign-up for Catalyst Pharmaceutical Partners Appoints Dr. Bernardino Mosquera as Vice President of Clinical Operations investment picks
2013/2/21
CORAL GABLES, Fla., Feb.
Sign-up for Catalyst Pharmaceutical Partners Launches New Website investment picks
2013/2/11
CORAL GABLES, Fla., Feb.
Sign-up for Catalyst Pharmaceutical Partners Provides Update on Research and Development Pipeline investment picks
2013/5/16
CORAL GABLES, Fla., May 16, 2013 (GLOBE NEWSWIRE) -- Catalyst Pharmaceutical Partners, Inc. (Nasdaq:CPRX) , a specialty pharmaceutical company focused on the development and commercialization of novel prescription drugs targeting rare (orphan) neuromuscular and neurological diseases, today announced financial results for the three month period ended March 31, 2013.
Sign-up for Catalyst Pharmaceutical Partners Reports First Quarter 2013 Financial Results investment picks
2013/4/2
CORAL GABLES, Fla., April 2, 2013 (GLOBE NEWSWIRE) -- Catalyst Pharmaceutical Partners, Inc. (Nasdaq:CPRX) , a specialty pharmaceutical company focused on the development and commercialization of novel prescription drugs targeting rare (orphan) neuromuscular and neurological diseases and disorders, today reported financial results for the fourth quarter and year ended December 31, 2012.
Sign-up for Catalyst Pharmaceutical Partners Reports Fourth Quarter and Year-End 2012 Financial Results investment picks
2013/2/5
CORAL GABLES, Fla., Feb.
Sign-up for Catalyst Pharmaceutical Partners to Present at 15th Annual BIO CEO & Investor Conference investment picks
2013/3/7
CORAL GABLES, Fla., March 7, 2013 (GLOBE NEWSWIRE) -- Catalyst Pharmaceutical Partners, Inc. (Nasdaq:CPRX) announced today that Patrick J.
Sign-up for Catalyst Pharmaceutical Partners to Present at 25th Annual ROTH Conference investment picks
2013/3/27
Catalyst Telecom®, a sales unit of ScanSource, Inc. (NASDAQ: SCSC) , and value-added distributor of voice, video and data convergence solutions, has been named US and Canada Distributor of the Year by Aruba Networks, a leading provider of next-generation network access solutions.
Sign-up for Catalyst Telecom Named US And Canada Distributor of the Year by Aruba Networks investment picks
2013/5/15
Catalyst Telecom®, a sales unit of ScanSource, Inc. (NASDAQ: SCSC) , and value-added distributor of voice, video and data convergence solutions, is now, through an OEM relationship, offering industry-leading storage solutions from EMC Corporation (NYSE:EMC) , a global leader in enabling businesses and service providers to transform their operations and deliver information technology as a service.
Sign-up for Catalyst Telecom Now Offering EMC Storage Solutions investment picks
2013/5/2
Catamaran Corp.'s (CTRX, CCT.T) first-quarter profit surged as the pharmacy-benefit manager's sales and margins were boosted by its acquisition of rival Catalyst Health Solutions last year.
Sign-up for Catamaran 1st-Quarter Profit Soars But Revenue Misses Estimates; Shares Down investment picks
2013/2/28
Catamaran Corporation Announces Record Setting Results for 2012 Canada NewsWire -Record setting year reaches $9.9 billion in revenue and $116.7 million in net income- -Quarterly revenue of $3.3 billion and EBITDA of $146.6 million reach all time highs- -2013 Revenue and EPS (fully-diluted) expected to grow 45% and 74%- LISLE, IL, Feb.
Sign-up for Catamaran Corporation Announces Record Setting Results for 2012 investment picks
2013/2/28
-Record setting year reaches $9.9 billion in revenue and $116.7 million in net income- -Quarterly revenue of $3.3 billion and EBITDA of $146.6 million reach all time highs- -2013 Revenue and EPS (fully-diluted) expected to grow 45% and 74%- LISLE, IL , Feb.
Sign-up for Catamaran Corporation Announces Record Setting Results for 2012 investment picks
2013/5/2
Catamaran Corporation Announces Strong First Quarter Financial Results Canada NewsWire -Revenue of $3.2 billion increases 88% versus Q1 2012- -Record Quarterly Net Income of $51.4 million- LISLE, IL, May 2, 2013 /CNW/ - Catamaran Corporation ("Catamaran" or the "Company") (NASDAQ: CTRX, TSX: CCT), a leading provider of pharmacy benefit management ("PBM") services and technology, announces its financial results for the three month period ended March 31, 2013.
Sign-up for Catamaran Corporation Announces Strong First Quarter Financial Results investment picks
2013/5/2
-Revenue of $3.2 billion increases 88% versus Q1 2012- -Record Quarterly Net Income of $51.4 million - LISLE, IL , May 2, 2013 /PRNewswire/ - Catamaran Corporation ("Catamaran" or the "Company") (NASDAQ: CTRX, TSX: CCT), a leading provider of pharmacy benefit management ("PBM") services and technology, announces its financial results for the three month period ended March 31, 2013 .
Sign-up for Catamaran Corporation Announces Strong First Quarter Financial Results investment picks
2013/2/15
Catamaran to Host 2012 Fourth Quarter and Year-End Conference Call Canada NewsWire Please dial in 10-15 minutes prior to the call to secure a line.
Sign-up for Catamaran to Host 2012 Fourth Quarter and Year-End Conference Call investment picks
2013/4/18
Catamaran to Host 2013 First Quarter Conference Call Canada NewsWire Please dial in 10-15 minutes prior to the call to secure a line.
Sign-up for Catamaran to Host 2013 First Quarter Conference Call investment picks
2013/4/18
LISLE, IL , April 18, 2013 /PRNewswire/ - Catamaran (NASDAQ: CTRX) (TSX: CCT) announces that it will release its fiscal 2013 first quarter financial results on Thursday, May 2, 2013 , at 6:00 AM Eastern Time .
Sign-up for Catamaran to Host 2013 First Quarter Conference Call investment picks
2013/5/6
Catamaran to Present at Bank of America Merrill Lynch 2013 Health Care Conference Canada NewsWire Catamaran's presentation will be webcast live, to access the webcast go to: http://www.veracast.com/webcasts/baml/healthcare2013/id49432000.cfm .
Sign-up for Catamaran to Present at Bank of America Merrill Lynch 2013 Health Care Conference investment picks
2013/5/6
LISLE, IL , May 6, 2013 /PRNewswire/ - Catamaran (NASDAQ: CTRX) (TSX: CCT) , a leading provider of technology and pharmacy benefit management (PBM) services, announces that Jeff Park , Executive Vice President and Chief Financial Officer, will present at the Bank of America Merrill Lynch 2013 Health Care Conference in Las Vegas, Nevada .
Sign-up for Catamaran to Present at Bank of America Merrill Lynch 2013 Health Care Conference investment picks
2013/3/8
Catamaran to present at Barclays Global Healthcare Conference Canada NewsWire Catamaran's presentation will be webcast live, to access the webcast go to: http://cc.talkpoint.com/barc002/031213a_lp/?entity=38_Y3RW07C .
Sign-up for Catamaran to present at Barclays Global Healthcare Conference investment picks
2013/3/8
LISLE, IL , March 8, 2013 /PRNewswire/ - Catamaran (NASDAQ: CTRX) (TSX: CCT) , a leading provider of technology and pharmacy benefit management (PBM) services, announces that Jeff Park , Executive Vice President and Chief Financial Officer, will present at the Barclays Global Healthcare Conference 2013 in Miami, Florida .
Sign-up for Catamaran to present at Barclays Global Healthcare Conference investment picks
2013/2/26
Catamaran to present at the Cowen Health Care Conference Canada NewsWire About Catamaran Catamaran, the industry's fastest-growing pharmacy benefits manager, helps organizations and the communities they serve take control of prescription drug costs.
Sign-up for Catamaran to present at the Cowen Health Care Conference investment picks
2013/2/26
LISLE, IL , Feb.
Sign-up for Catamaran to present at the Cowen Health Care Conference investment picks
2013/2/6
Catamaran to present at the Leerink Swann Global Healthcare Conference Canada NewsWire Catamaran's presentation will be webcast live, to access the webcast go to: http://leerink.metameetings.com/webcasts/healthcare13/directlink.php?p=35 .
Sign-up for Catamaran to present at the Leerink Swann Global Healthcare Conference investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Morningstar Investing Classroom Rewards (earn as you learn and redeem for Morningstar merchandise)
P   Morningstar Fund Analyst Reports (full research on 2,000 funds and ETFs)
P   Morningstar Stock Analyst Reports (full research on 2,000 stocks)
P   Morningstar Stock and Fund Stewardship Grades
P   Portfolio Manager (advanced with 10 x-ray analyses, including guidance)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Catalyst Paper Q4 results impacted by lower sales volumes, higher maintenance and stronger Canadian dollar to Catamaran to present at the Leerink Swann Global Healthcare Conference
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity